Granisetron intranasal - Athenex
Latest Information Update: 07 Jan 2016
At a glance
- Originator Athenex
- Class Analgesics; Antiemetics; Azabicyclo compounds; Indazoles; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Chemotherapy-induced nausea and vomiting
Most Recent Events
- 15 Dec 2015 Phase-I clinical trials in Chemotherapy induced nausea and vomiting in Hong Kong (Intranasal)